華特氣體(688268.SH)網上發行最終中籤率為0.04319934%
格隆匯12月22日丨華特氣體(688268.SH)發佈,本次發行價格為22.16元/股,發行數量為3,000.00萬股,全部為公開發行新股。由於網上初步有效申購倍數為3,086.4669倍,高於100倍,發行人和保薦機構(主承銷商)決定啟動回撥機制,將285.00萬股股票由網下回撥至網上。
回撥機制啟動後,網下最終發行數量為1,710.00萬股,佔扣除戰略配售數量後發行總量的60.00%;網上最終發行數量為1,140.00萬股,佔扣除戰略配售數量後發行總量的40.00%。回撥機制啟動後,網上發行最終中籤率為0.04319934%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.